IL120558A - Hormonal drugs and their uses for repairing estrogen deficiencies - Google Patents

Hormonal drugs and their uses for repairing estrogen deficiencies

Info

Publication number
IL120558A
IL120558A IL12055896A IL12055896A IL120558A IL 120558 A IL120558 A IL 120558A IL 12055896 A IL12055896 A IL 12055896A IL 12055896 A IL12055896 A IL 12055896A IL 120558 A IL120558 A IL 120558A
Authority
IL
Israel
Prior art keywords
estradiol
dosis
estroprogestative
hormonal
combination
Prior art date
Application number
IL12055896A
Other languages
English (en)
Hebrew (he)
Other versions
IL120558A0 (en
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9481610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL120558(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Publication of IL120558A0 publication Critical patent/IL120558A0/xx
Publication of IL120558A publication Critical patent/IL120558A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL12055896A 1995-08-01 1996-07-29 Hormonal drugs and their uses for repairing estrogen deficiencies IL120558A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9509364A FR2737411B1 (fr) 1995-08-01 1995-08-01 Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
PCT/IB1996/000754 WO1997004784A1 (fr) 1995-08-01 1996-07-29 Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques

Publications (2)

Publication Number Publication Date
IL120558A0 IL120558A0 (en) 1997-07-13
IL120558A true IL120558A (en) 2002-09-12

Family

ID=9481610

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12055896A IL120558A (en) 1995-08-01 1996-07-29 Hormonal drugs and their uses for repairing estrogen deficiencies

Country Status (30)

Country Link
US (1) US5891867A (cs)
EP (1) EP0783310B1 (cs)
JP (1) JPH10507207A (cs)
KR (1) KR100450649B1 (cs)
CN (1) CN1138547C (cs)
AP (1) AP829A (cs)
AR (1) AR004502A1 (cs)
AT (1) ATE225659T1 (cs)
AU (1) AU722355B2 (cs)
BR (1) BR9606549A (cs)
CA (1) CA2201368C (cs)
CZ (1) CZ289706B6 (cs)
DE (1) DE69624214T2 (cs)
DK (1) DK0783310T3 (cs)
DZ (1) DZ2078A1 (cs)
ES (1) ES2184880T3 (cs)
FR (1) FR2737411B1 (cs)
HU (1) HU229843B1 (cs)
IL (1) IL120558A (cs)
MA (1) MA23946A1 (cs)
MX (1) MX9702381A (cs)
MY (1) MY117307A (cs)
NO (1) NO312996B1 (cs)
OA (1) OA10411A (cs)
PT (1) PT783310E (cs)
RU (1) RU2188641C2 (cs)
TN (1) TNSN96101A1 (cs)
TW (1) TW473390B (cs)
WO (1) WO1997004784A1 (cs)
ZA (1) ZA966545B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
US20020151732A1 (en) * 2001-01-05 2002-10-17 Claes Ohlsson Estrogen receptors
EP1390038A2 (en) 2001-05-16 2004-02-25 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
CN100581550C (zh) * 2001-12-05 2010-01-20 杜拉美德药物有限公司 预防怀孕和减少经期前症状的口服避孕药
US7008979B2 (en) * 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
CN101001631B (zh) * 2003-07-16 2014-08-06 特卫华妇女健康有限公司 利用连续给予雌激素的避孕方案的激素治疗方法
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
PE20081895A1 (es) * 2007-03-26 2009-01-26 Theramex Regimen anticonceptivo oral

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4870066A (en) * 1986-08-11 1989-09-26 The University Of Kentucky Research Foundation Method and composition for safely delaying parturition and synchronizing farrowing in swine
DE69115221T2 (de) * 1990-09-28 1996-08-22 I F L O S A S Di Giorgio E Ald Methode zur Synthese eines Präparats zur Regulation der Empfängnis und des Menstruationszyklus mit onkostatischen antikinetosischen, preventiven und therapeutischen Eigenschaften zur Behandlung von Brustkrebs und Melanomen.
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.

Also Published As

Publication number Publication date
DZ2078A1 (fr) 2002-10-22
CA2201368A1 (fr) 1997-02-13
KR100450649B1 (ko) 2004-11-16
HUP9900612A3 (en) 1999-11-29
DK0783310T3 (da) 2003-02-10
FR2737411B1 (fr) 1997-10-17
HU229843B1 (en) 2014-09-29
OA10411A (fr) 2001-12-06
AU722355B2 (en) 2000-07-27
US5891867A (en) 1999-04-06
CZ289706B6 (cs) 2002-03-13
DE69624214T2 (de) 2003-07-10
DE69624214D1 (de) 2002-11-14
NO312996B1 (no) 2002-07-29
MY117307A (en) 2004-06-30
JPH10507207A (ja) 1998-07-14
HK1005227A1 (en) 1998-12-31
CA2201368C (fr) 2010-12-07
RU2188641C2 (ru) 2002-09-10
TNSN96101A1 (fr) 2005-03-15
ES2184880T3 (es) 2003-04-16
WO1997004784A1 (fr) 1997-02-13
CN1167438A (zh) 1997-12-10
AR004502A1 (es) 1998-12-16
EP0783310A1 (fr) 1997-07-16
HUP9900612A2 (hu) 1999-07-28
ZA966545B (en) 1997-05-08
FR2737411A1 (fr) 1997-02-07
TW473390B (en) 2002-01-21
IL120558A0 (en) 1997-07-13
MX9702381A (es) 1998-02-28
CZ96797A3 (cs) 1998-08-12
NO971449L (no) 1997-05-30
AP829A (en) 2000-05-03
AU6367496A (en) 1997-02-26
CN1138547C (zh) 2004-02-18
AP9700979A0 (en) 1997-07-31
BR9606549A (pt) 1998-06-23
NO971449D0 (no) 1997-03-26
KR970706004A (ko) 1997-11-03
EP0783310B1 (fr) 2002-10-09
MA23946A1 (fr) 1997-04-01
ATE225659T1 (de) 2002-10-15
PT783310E (pt) 2003-02-28

Similar Documents

Publication Publication Date Title
US11896602B2 (en) Method for preventing pregnancy
CN1137691C (zh) 基于天然雌激素的多相避孕制剂
US9084796B2 (en) Hormonal composition and its use
US5891867A (en) Hormonal medicaments and their use for the correction of oestrogenic deficiencies
CN1186024C (zh) 单阶段避孕方法和含有黄体酮和雌激素组合物的避孕药盒
NZ565829A (en) Oral contraception with trimegestone at a dose of over 500ug per day and 5 to 55ug ethinyloestradiol
KR100782638B1 (ko) 에스트로겐 화합물 및 프로게스테론 화합물로 이루어진호르몬 조성물
AU759925B2 (en) Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
AU784478B2 (en) Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same
TW200306846A (en) Hormone replacement therapy
JPH08508502A (ja) 骨粗しょう症の治療方法および治療用組成物
CA2371635A1 (en) Use of antiprogestagens in combined therapy
MXPA99003291A (en) Hormonal composition consisting of an oestrogen compound and of a progestational compound
HK1129564B (en) Method of contraception based on a progestative and oestrogen

Legal Events

Date Code Title Description
NP Permission for amending the patent specification granted (section 66, patents law 1967)
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired